YSB

YSB Financial Leverage

The Financial Leverage (Equity Multiplier) of YSB (9885.HK) as of Oct 18, 2026 is 3.10. In the previous year, Financial Leverage (Equity Multiplier) was 2.80 — a change of 10.51% (higher).

Financial Leverage

3.10

YoY

10.51%

Last updated:

Financial Leverage (Equity Multiplier) of YSB is 2025 3.10 . Financial Leverage (Equity Multiplier) of YSB was 2024 2.80 . It decreases by 10.51% higher compared to the previous year.

The YSB Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
-1.05 CNY
Jan 1, 2021
-1.18 CNY
Jan 1, 2022
-0.94 CNY
Jan 1, 2023
2.71 CNY
Jan 1, 2024
2.80 CNY
Jan 1, 2025
3.10 CNY
The YSB Financial Leverage history
YEARFinancial LeverageYoY
3.10+10.51%
2.80+3.16%
2.71-387.48%
-0.94-20.28%
-1.18+12.59%
-1.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB Inc, listed on the Hong Kong Stock Exchange under ticker 9885.HK with ISIN KYG9879S1003, is a healthcare company headquartered in Guangzhou, China. The company went public on June 28, 2023, and currently employs 6,108 full-time staff. YSB Inc operates within the healthcare sector, focusing on the wholesale and retail of pharmaceuticals and healthcare products through both online and offline channels. The company provides an online platform enabling pharmaceutical distributors to sell their products. Additionally, it offers software-as-a-service (SaaS) solutions tailored for pharmacies, medical testing services for primary healthcare institutions, and sells smart unmanned pharmaceutical booths to third-party pharmacies. Maintenance and technical support services related to these booths are also provided. YSB Inc primarily serves the domestic Chinese market, with its operations centered in Guangzhou. The company's business model integrates digital solutions with physical healthcare distribution, aiming to streamline the supply chain for pharmaceutical products. Its online platform connects distributors with end-users, while its SaaS offerings support pharmacy operations. The firm's focus on smart unmanned pharmaceutical booths reflects its investment in innovative retail solutions within the healthcare sector. YSB Inc's services are designed to enhance efficiency and accessibility in the pharmaceutical distribution network across China. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

Financial Leverage (Equity Multiplier) of YSB is 3.10 in 2025.

Financial Leverage (Equity Multiplier) of YSB changed from 2.80 to 3.10, representing a 10.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) YSB since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s YSB with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — YSB

All Key Metrics — YSB